Skip to main content

Table 1 Characteristics of subjects after excluding subjects with missing values

From: Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes

 

NMIBC (n = 603)

Age

 

Median (Q1, Q3)

66 (57,71)

Sex

 

Male

457 (75.8%)

Female

146 (24.2%)

Tumor grade

 

Grade 1

290 (48.1%)

Grade 2

162 (26.9%)

Grade 3

125 (20.7%)

Grade 4

26 (4.3%)

Smoking status

 

Never

103 (17.1%)

Ever

500 (82.9%)

BCG: immunotherapy

 

No

514 (85.2%)

Yes

89 (14.8%)

NLR

 

Median (Q1, Q3)

1.97 (1.40, 2.93)

10-year dead status

 

Alive

423 (70.1%)

Deceased

180 (29.9%)

10-year survival

 

Median (Q1, Q3)

120.0 (105, 120)

10-year recurrence status

 

No

193 (32.0%)

Yes

295 (48.9%)

Missing

115 (19.1%)

10-year recurrence

 

Median (Q1, Q3)

17.7 (6.9, 67.1)

Missing

115

  1. Exclude subjects with missing values in muscle-invasive status, pathology reviewing status, tumor grade, smoking status, or pack-years